Prenetics Global is trading 5.20% lower at $19.87 on October 6, 2026, with no direct cause confirmed.
- Biotech shares were also under pressure: XBI was reported down 3.51% during the session.
- The supplied market indices were higher, so broad-market weakness does not explain the decline.
- Prenetics Globalβs investor-relations page lists its latest press releases in August, not October 6.